The Complex World of Polysaccharides
612
The results described in the current work demonstrated the wide range of possibilities in the
studies of interaction between chitosan, used in diets as anti-obesity supplement, and
molecules that are present in the human body, as well as with other drugs. Moreover, our
work demonstrates the need for more studies on the subject as a means of providing
information on the use of chitosan in diets as anti-obesity supplement.
Author details
Máira Regina Rodrigues
*
Universidade Federal Fluminense, Polo Universitário de Rio das Ostras, Rio das Ostras, RJ, Brazil
Alexandre de Souza e Silva and Fábio Vieira Lacerda
Centro Universitário de Itajubá, Instituto de Ciências Biológicas, BairroVarginha, Itajubá,
MG, Brazil
Acknowledgement
The authors thank CNPq and FAPESP for the financial support.
5. References
Alda, M.J.L.; Parceiro, P.; Goicoechea, A.G. (1996). Rapid zero-order and second-derivative
UV spectrophotometric determination of cyanocobalamin in pharmaceutical
formulations containing dextran and preservatives. Journal of Pharmaceutical and
Biomedical Analysis, 14:363-365.
Aslander-van Vliet, E.; Smart, C.; Waldron, S. (2007). Nutritional management in childhood
and adolescent diabetes. Pediatric Diabetes, 8:323-339.
Association of Official Analytical Chemists. (2005). Official Methods of Analysis of the
Association Analytical Chemists. 18th ed. Gaithersburg, MD: AOAC.
Barbosa, L.S.; Pazdziora, A.Z.; Kojima, A.S.G.; Martins, M.S.F.; Ferreira, C.L.P.; Macêdo,
G.S.; Latorraca, M.Q.; Gomes-da-Silva, M.H.G. (2007). Effects of chitosan over some
nutritional and biochemical parameters in rats. Journal of Brazilian Society of Food and
Nutrition, 32:1-13.
Böer, U.; Noll,
C.; Cierny, I.; Krause,
D.; Hiemke, C.; Knepel, W. (2010). A common
mechanism of action of the selective serotonin reuptake inhibitors citalopram and
fluoxetine: Reversal of chronic psychosocial stress-induced increase in CRE/CREB-
directed gene transcription in transgenic reporter gene mice. European Journal of
Pharmacology, 633:33-38.
British Pharmacopoeia. (1998). Her Majesty’s Stationery Office, London, p.413.
Cummings, J.H.; Roberfroid, M.B.; Andersson, H.; Barth, C.; Ferro-Luzzi, A.; Ghoos, Y.;
Gibney, M.; Hermansen, K.; James, W.P.T.; Korver, O.; Lairon, D.; Pascal, G.; Voragen,
*
Corresponding Author
The Chitosan as Dietary Fiber: An
in vitro Comparative
Study of Interactions with Drug and Nutritional Substances 613
A.G.S. (2010). A new look at dietary carbohydrate: chemistry, physiology and health.
European Journal of Clinical Nutrition, 64:334-339.
Dacome, L. (2005). Useless and pernicious matter: corpulence in eighteenth-century britain.
In: Cultures of the abdomen: diet, digestion and fat in the modern world. Eds: A. Carden-
Coyne and C. Forth. Palgrave, New York.
Darwish, I.A. (2005). Development and validation of spectrophotometric methods for
determination of fluoxetine, sertraline, and paroxetine in pharmaceutical dosage forms.
Journal of AOAC International, 88:38-45.
Deuchi, K.; Kanauchi, O.; Imasato, Y.; Kobayashi, E. (1994). Decreasing effect of chitosan on
the apparent fat digestibility by rats fed on a high-fat diet. Bioscience Biotechnology &
Biochemistry, 58:1613-1616.
Fregonezi-Nery, M.M.; Baracat, M.M.; Casagrande, R.; Machado, H.T.; Miglioranza, B.;
Gianotto, E.A.S. (2008). Validação de métodos para determinação de fluoxetina em
cápsulas. Química Nova, 31:1665-1669.
Gades, M.D.; Stern, J.S. (2005). Chitosan supplementation and fat absorption in men and
women. Journal of the American Dietetic Association, 105:72-77.
Gomes, A.J.; Faustino, A.S.; Machado, A.E.H.; Zaniquelli, M.E.; Rigoletto, T.P.; Lunardi, C.N.
(2006). Characterization of PLGA microparticle as a drug carrier for the compound 3-
ethoxycarbonyl-2H-benzofuro[3,2-d]-1-benzopyran-2-one. Ultra structural study of
cellular up take and intracellular distribution. Drug Delivery, 13:447–454.
Gomes, A.J.; Assunção, R.M.N.; Rodrigues Filho, G.; Espreafico, E.M.; Machado, A.E.H.
(2007). Preparation and characterization of poly(D,L-lactic-co-glycolicacid)
nanoparticles containing 3-(benzoxazol-2-yl)-7-(N,N-diethylamino)cromen-2-one.
Journal of Applied Polymer Science, 105:964–972.
Hennen, W.J. (2005). Chitosan. Woodland Publishing Inc., Pleasant Grove, Utah.
Hirano, S.; Akiyama, Y. (1995). Absence of a hypocholesterolaemic action of chitosan in
high-serum-cholesterol rabbits. Journal of the Science of Food and Agriculture, 69:91-94.
Ho, S.C.; Tai, E.S.; Eng, P.H.; Tan, C.E.; Fok, A.C. (2001). In the absence of dietary
surveillance, chitosan does not reduce plasma lipids or obesity in
hypercholesterolaemic obese Asian subjects. The Singapore Medical Journal, 42:6–10.
Johnson, R.J.; Segal, M.S.; Sautin, Y.; Nakagawa, T.; Feig, D.I.; Kang, D.H.; Gersch, M.S.;
Benner, S.; Sánchez-Lozada, L.G. (2007). Potential role of sugar (fructose) in the
epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney
disease, and cardiovascular disease. The American Journal of Clinical Nutrition, 86:899-
906.
Jull, A.B.; Ni Mhurchu, C.; Bennett, D.A.; Dunshea-Mooij, C.A.; Rodgers, A. (2008). Chitosan
for overweight or obesity. Cochrane Database System Review, 16:CD003892.
Kaats, G.R.; Michalek, J.E.; Preuss, H.G. (2006). Evaluating eficacy of a chitosan product
using a double-blinded, placebo-controlled protocol. Journal of the American College of
Nutrition, 25:389-394.
Kalyanasundaram. K.; Thomas, J.K. (1977). Environment effects on vibronic band intensities
in pyrene monomer fluorescence and their application in studies of micellar systems.
Journal of the American Chemical Society, 99:2039–2044.